HomeLatest NewsCovid-19CMS announces Medicare Coverage for COVID-19 Antibody Treatment

CMS announces Medicare Coverage for COVID-19 Antibody Treatment

​The Centers for Medicare and Medicaid Services (CMS) announced that effective November 10, 2020, Medicare beneficiaries can receive coverage of monoclonal antibodies for treatment of COVID-19 with no cost-sharing during the public health emergency. CMS’ coverage of monoclonal antibody infusions applies to bamlanivimab, which received an emergency use authorization from the U.S. Food and Drug Administration on November 9, 2020.

CMS anticipates that this monoclonal antibody product will initially be given to health care providers at no charge. Medicare will not pay for the monoclonal antibody products that providers receive free, but will provide reimbursement for the infusion of the product when providers begin to purchase monoclonal antibody products. Medicare anticipates setting the payment rate in the same way it set the payment rates for COVID-19 vaccines, such as based on 95% of the average wholesale price for COVID-19 vaccines in many provider settings.

CMS further expects Medicaid programs to cover monoclonal antibody infusions during the public health emergency in accordance with Section 6008 of the Families First Coronavirus Response Act.

Stay Connected

Unified Voice Newsletter

Events This Month

december

05dec12:00 pm1:00 pmBecoming the Employer of Choice - How Organizations Create "Stickiness" for their WorkersSDAHO Webinar

05dec12:00 pm1:00 pmRural Hospital Growth Is Possible: How Expanding Critical Services Can Drive ResultsAHA Webinar

06dec1:00 pm2:00 pmSubstance Misuse Prevention Strategies to Improve Public Health: A Focus on State PracticesODPHP Webinar

06dec1:30 pm2:30 pmMedical Complexities of Chronic Opioid UseHazelden Betty Ford Webinar

07dec11:30 am12:45 pmFacility Safety and Security in Health CareAHA Webinar


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact